|Quest Diagnostics and Rutgers University Announce Sports Science Research Collaboration to Advance Athletic Performance|
|Collaboration will leverage insights from Quest’s Blueprint for Athletes biometric testing service data to examine physiological changes, performance variables in competitive athletes at the newly created Quest Diagnostics Sports Science Laboratory at the Rutgers–New Brunswick Center for Health & Human Performance
Secaucus, NJ and New Brunswick, NJ, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, and Rutgers... ||02/26/18|
|Quest Diagnostics To Speak At The Raymond James 39th Annual Institutional Investors Conference|
|SECAUCUS, N.J., Feb. 22, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Raymond James 39th Annual Institutional Investors Conference in Orlando. Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, March 6, 2018 at ... ||02/22/18|
|Quest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per Quarter|
|- Fourth quarter revenues of $1.94 billion, up 4.1% versus 2016
- Fourth quarter diluted EPS of $1.82 on a reported basis, up 67.0% from 2016 primarily due to a tax benefit recorded as a result of the Tax Cuts and Jobs Act (TCJA); and $1.40 on an adjusted basis excluding amortization, up 6.9% from 2016. Excess tax benefit associated with stock based compensation (ETB) benefited diluted EPS by $0.02 in the quarter and increased $0.01 compared to 2016.
- Full year revenues of $7.71 billion, ... ||02/01/18|
|Quest Diagnostics Completes Acquisition of MedXM|
|Transaction expands Quest’s scale and reach in the mobile provider segment and bolsters its extended care capabilities
Secaucus, NJ, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of Mobile Medical Examination Service (MedXM), a leading national provider of home-based health risk assessments and related services.
The acquisition will stren... ||02/01/18|